Vaccine Clinic Offers Choice and Reassurance to New Haven Children
Corinne Scott, 8, and Chidera Ogbuagu, 10, lined up at a vaccine clinic at Elm City Montessori School in New Haven on November 6th. Helping children like Chidera and Corinne feel good about getting vaccinated is a key part of the vaccine effort’s broader success.
Vaccine Found Effective for Elderly in Hard-hit Brazil Facing COVID-19 Gamma Variant
The AstraZeneca vaccine, which is being widely used in Brazil and elsewhere in response to an epidemic wave of the SARS-CoV-2 Gamma variant, affords significant protection to the elderly when the vaccine’s full two-dose schedule is completed.
22 Immunization Experts from Ghana, Kenya, Malawi, Somalia and Uganda Graduate from the EPI LAMP Program
On May 17, 2021, 22 delegates from Ghana, Kenya, Malawi, Somalia and Uganda graduated from the Expanded Program on Immunisation Leadership and Management Programme (EPI LAMP), a 9-month certificate programme offered by Yale’s Global Health Leadership Initiative (GHLI) in partnership with the University of Global Health Equity (UGHE) and PATH.
COVID-19 Vaccine Found to Be Effective against Brazilian P.1 Variant
The inactivated vaccine, CoronaVac, proved effective in combatting COVID-19 in the city of Manaus, Brazil, where the highly transmissible P.1 variant emerged and has devastated the local population, researchers from Brazil and the Yale School of Public Health have found.
COVID-19 Vaccines Found to Be Highly Effective in Nursing Homes, Study Finds
In what is believed to be the first published study of COVID-19 vaccine effectiveness in long-term care facilities such as nursing homes, a research team co-led by the Yale School of Public Health found a widely used vaccine is highly successful in preventing infections.Source: YaleNews
Home-based rapid testing for COVID-19 could prevent infections
Mailing a package of SARS-CoV-2 tests to every household in America and asking people to use them once a week could greatly reduce total infections and mortality at a justifiable cost, a new study led by the Yale School of Public Health (YSPH) finds.Source: Yale News
Yale and Columbia Create Interactive Vaccine Allocation Map
An interactive map of each county in each state proposing how COVID-19 vaccinations could be distributed is now publicly available, providing an important tool for policymakers and the public alike to analyze differences between multiple distribution strategies as well as issues surrounding equity and vulnerability of at-risk groups.
Opinion: The Vaccine Line Is Illogical
In mid-January, I got an email telling me that I should schedule a visit to get my COVID-19 vaccination. I was a little surprised, as I am only 57 years old and didn’t think I qualified for the shot. I am also HIV-positive, but that shouldn’t move me ahead in line; my virus is well controlled on antiretroviral therapy, and my life expectancy is near normal. I am a professor at a public-health school, but that does not make me an essential worker. Meanwhile, my 86-year-old mother, who lives in New York, just one state over from where I live in Connecticut, is dutifully waiting for a call from her doctor’s medical network to tell her to come in for her first vaccine dose. I told her not to hang by the phone, as I doubted anyone would be calling soon.Source: The Atlantic
The Secret Weapon for Distributing a Potential Covid-19 Vaccine
Storing and distributing a vaccine — especially the potential Pfizer vaccine, which must be frozen until use at -70°C, around the temperature of dry ice — poses a significant challenge. Rural cattle breeders offer a solution.Source: The Washington Post
Yale Cancer Center Partners in Fight to Help Eliminate HPV-related Cancers
Yale Cancer Center joins the Association of American Cancer Institutes (AACI) and its partner organizations to endorse a Call to Action for our nation to work together toward the elimination of human papillomavirus (HPV)-related cancers.
Researchers at Yale School of Public Health, GHLI Receive Funding from Gates Foundation for Global Projects
Researchers at the Yale School of Public Health and the Yale Global Health Leadership Initiative, in collaboration with international peers, have received Grand Challenges Explorations grants from the Bill & Melinda Gates Foundation for innovative research.
Vaccine Is a Cost-effective Solution for Countries Burdened by Typhoid
Introducing a typhoid conjugate vaccine (TCV) into routine child vaccine schedules and conducting a catch-up campaign to vaccinate all children up to age 15 is a cost-effective solution for many low- to middle-income countries severely burdened by typhoid, a new study led by researchers at the Yale School of Public Health finds.